Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Tag: biologic therapies

Miguel Reguiero, MD
October 23, 2023/Digestive/Research

No Link Between Small Molecule Therapies and Cardiovascular Events in New IBD Study

Underlying inflammation may cause higher rates of CV events

Female patient sitting on exam table in clinic room
October 24, 2022/Digestive/Research

Study Reveals Racial Disparities in Treatment of Inflammatory Bowel Disease

Black patients less likely to receive advanced therapies

Kurowski_1177164228

Biologic Therapies Are Lowering the Rate of Abdominal Surgeries for Crohn’s Disease

Results from an artificial intelligence model

bowels

Higher Biologic Use in Crohn’s Disease Associated With Lower Abdominal Surgery Rate

Study further validates the role of biologics in improving outcomes

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Tuberculosis

Balancing the Benefits of Biologic Therapy for Autoimmune Disease Against the Risks of Mycobacterial Infections

Management pearls from a new expert review

TNF alpha with infliximab fab fragment from NCBI
May 22, 2020/Digestive/Research

TARGET-IBD Findings Demonstrate Need for Objective Evaluation Prior to Therapy Changes

Too few patients assessed before undergoing biologic dose changes

15-RHE-963-Deal-Hero-Image-690x380pxl

Biologic Therapies for Metabolic Bone Disease

Beyond bisphosphonates

16-DDI-052-Biosimilars-CQD+650×450

Deadly but Preventable: HBV Reactivation After Immunosuppressive Treatment

Hepatitis B reactivation a concern

BackPage 1 of 1Next

Advertisement

Ad